Ypsomed is a leading Swiss developer and manufacturer of injection and infusion systems for self-medication, specializing in insulin pumps and diabetes care products.
The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years of experience. Headquartered in Burgdorf, Switzerland, the company acts as a preferred partner for pharmaceutical and biotech companies, supplying pens, autoinjectors, and infusion systems for administering liquid drugs.
Ypsomed markets its product portfolio under the umbrella brand "mylife Diabetescare" directly to patients, pharmacies, and clinics, and under the "Ypsomed Delivery Systems" brand for business-to-business partnerships. Their flagship innovations include the mylife YpsoPump, an intuitive insulin pump system, and the Orbit line of infusion sets, all designed to make medical self-treatment simple and reliable.
Naujausi vadovai iš manuals+ šiam prekės ženklui kuruota.
Dažniausiai užduodami klausimai apie šio prekės ženklo vadovus, registraciją ir palaikymą.
„mylife YpsoPump“ parodys, kada reikia pakeisti kasetę, per ekrane pateikiamus raginimus ir įspėjimus, susijusius su kasetės / rezervuaro lygiu.
Taip, galite sukurti ir koreguoti „Basal Rate Pro“.files A ir B, kad atitiktų jūsų individualius insulino poreikius.
Jei įrenginyje matote elektroninės klaidos piktogramą, ieškokite trikčių šalinimo veiksmų vartotojo vadove arba kreipkitės pagalbos į klientų aptarnavimo tarnybą.
Ypsomed manufactures injection and infusion systems for self-medication, including the mylife YpsoPump insulin pump, Orbit infusion sets, pens, and autoinjectors.